Clinical Trials Logo

Nephrolithiasis clinical trials

View clinical trials related to Nephrolithiasis.

Filter by:
  • Active, not recruiting  
  • « Prev · Page 3

NCT ID: NCT01215708 Active, not recruiting - Renal Calculi Clinical Trials

Effects of the Use of Adjuvant Drugs After Extracorporeal Shockwave Lithotripsy (ESWL) in Renal Calculus

Start date: August 2006
Phase: Phase 3
Study type: Interventional

The investigators objective is to study if some drugs can improve the success rate of extracorporeal shockwave lithotripsy for renal stones.

NCT ID: NCT00959153 Active, not recruiting - Kidney Stones Clinical Trials

Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney

Start date: June 2010
Phase: Phase 3
Study type: Interventional

A total of 20 subjects presenting with urinary stone(s) in the kidney or ureter will be treated with an extracorporeal shockwave lithotripsy device to fragment the stones. Subjects will be followed for 14 days. If at the 14 day follow-up visit the subject continues to present with a stone size 4 mm or greater will have an option of retreatment or other intervention. If the subject consents to be retreated at this time, this subject will be followed up for another 14 days.

NCT ID: NCT00759343 Active, not recruiting - Kidney Stones Clinical Trials

Stone Centre Urine and Serum Bank

Start date: June 2008
Phase:
Study type: Observational

Purpose: The purpose of the Stone Centre Serum and Urine Bank is to provide researchers with large numbers of serum and urine samples from kidney stone patients and controls for study of stone disease detection and treatment, and will take into account different genetic backgrounds, ages, and other patient factors to provide a broad sample size for the study of stone disease The Serum and Urine Bank will undoubtedly be an invaluable tool in the quest to understanding urinary stone disease. Objective: The objective of this research is to identify protein species or other compounds responsible for or contributing to kidney stone initiation and propagation.

NCT ID: NCT00323843 Active, not recruiting - Kidney Stone Clinical Trials

Retrograde Intrarenal Stone Surgery - A Method of Treating the ESWL Resistant Kidney Stone

Start date: June 2006
Phase: Phase 2
Study type: Interventional

Is it possible to decrease the intrarenal pressure in the kidney during endoscopic management of kidney stone by topical administration of drugs? In order to secure fewer complications in ureteroscopic operations the pharmacological agent isoproterenol is tested on pigs and human to determine its potential of lowering intrarenal pressure.